Border Image


Lake Nona Impact Forum 2022

“Health Innovation In The New Reality” was the theme of the Lake Nona Impact Forum 2022, ensuring enthralling talks and a lively exchange on new health technologies. Speakers included Bill Clinton, Karen DeSalvo, Google’s Chief Health Officer, James Weinstein, Microsoft’s...
mehr lesen

Cardisio GmbH Acquires Assets of Enverdis GmbH

Addition of Diagnostic Products, Research Data, Patents and Technology Complements Cardisio’s Platform for AI-Based Heart Health Frankfurt, Germany, January 31., 2022—Cardisio GmbH, developer of the world’s first non-invasive, highly accurate screening method for heart diseases, today announced the acquisition...
mehr lesen

Heart disease risk: how dangerous is COVID-19?

The German Heart Foundation provides detailed information for people with heart disease in the current corona crisis on its website. The motto is: be careful, but don’t panic. People over 60 are at higher risk of severe symptoms if...
mehr lesen


Cardisiography is now also registered with the “Therapeutic Good Administration” (TGA) for medical use in Australia. This clears another hurdle for the worldwide spread of cardisiography and the early detection of coronary diseases. Cardisio is present in Australia through...
mehr lesen

Cardisio Validation Study Sana-Heart Center Cottbus

Frankfurt, March 10, 2020: Following the initial clinical study published in the Journal of Electrocardiography in December, a second, independent study now confirms the effectiveness of cardisiography in the detection of coronary artery disease (CAD). In the study, the...
mehr lesen

Cardisio in the press